BackCaliPharms Overview

CaliPharms Net Tangible Assets

Track CaliPharms's net tangible assets ($-8.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$-8.79M
↑ 1771.50% YoYΔ $-8.32M vs prior year quarter

Peer average

Loading

CaliPharms Net Tangible Assets History

Loading

CaliPharms vs. peers: Net Tangible Assets Comparison

Loading

CaliPharms Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CaliPharms (KGET) FAQ

CaliPharms (KGET) currently reports a net tangible assets of $-8.8M as of September 2014. That compares with $-470K in the prior-year period — down 1771.5% year over year. Use the charts on this page to explore CaliPharms's net tangible assets history and peer comparisons.

CaliPharms's net tangible assets decreased from $-470K to $-8.8M — a 1771.5% year-over-year decrease (period ending September 2014). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CaliPharms reported $-8.8M in net tangible assets as of September 2014. That compares with $-470K in the prior-year period — down 1771.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-8.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CaliPharms, and consider following KGET for alerts when major investors trade the stock.

CaliPharms is classified in the Industrials sector. On net tangible assets, it currently shows $-8.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing KGET with unrelated industries.